Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from New Radiotracers

  • You have access
    In vitro response of 177Lu-PSMA-617 with two different specific activities
    Cristian Wieczorek Villas Boas, Jair Mengatti, Priscila Passos, Daniel Vieira and Elaine Bortoleti de Araujo
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 624;
  • You have access
    SPECT and PET imaging of CD11b-positive immune cells in an orthotopic mouse model of glioma with Zr-89 and Lu-177 labeled Lumi804-anti-CD11b antibody
    Shubhanchi Nigam, David Tatum, Alexandra Foster, Elizabeth Plakseychuk, Robert Edinger, Wilson Edwards, Gary Kohanbash, Darren Magda and Carolyn Anderson
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 621;
  • You have access
    A Unique 18F-labeled G-protein-coupled receptor 44 (GPR44) radiotracer: design, radio-synthesis and evaluation in the rodents
    Jiangling Peng, Wei Tang, Lynn Miao, Eryun Zhang, Nelson Gonzalez, Fouad Kandeel and Junfeng Li
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 622;
  • You have access
    Synthesis and Preliminary Evaluation of Metabolically Stable 18F-Lableled PET Tracer for Fatty Acid Beta-Oxidation Imaging.
    Yoshihiro Murakami, Yuji Fujita and Hiroshi Fushiki
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 617;
  • You have access
    Design of calcium-sensing receptor targeted thera(g)nostic agents
    Xiaonan Deng, Weiping Yu, Mingyong Li, Cassandra Miller, Yao Xin, Matthew Goodman, Jian Hu, Mark Goodman and Jenny Yang
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 618;
  • You have access
    Synthesis and preclinical evaluation of 11C-labeled (6-aryl-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide for imaging GluN2B subunit of NMDA receptors
    Jiyun SUN, Zhen Chen, Jiahui Chen, Hualong Fu, Tuo Shao, Lu WANG, Hao Xu, Ming-Rong Zhang and Steven Liang
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 616;
  • You have access
    Syntheses of [11C]2- and [11C]3-trifluoromethyl-4-aminopyridine: potential PET radioligands for imaging demyelinating diseases
    Karla Ramos-Torres, Yu-Peng Zhou, Bo Yeun Yang, Nicolas Guehl, Sanjay Telu, Marc Normandin, Victor Pike and Pedro Brugarolas
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 619;
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire